Thanks to the hard work of our team members, we have 14 papers in quartile 1 journals of which 12 are in the top 15%. @HealthcareAI_UK

Beautiful. You can search predatory publishers and journals! Group members, collaborators and friends. @FrontiersIn @MDPIOpenAccess

Our book on Internet of Things in diabetes mellitus is now available for pre-order at Elsevier or Amazon: lnkd.in/gsS6Zkkj Editors: Sujata Dash, Subhendu Kumar Pani, Willy Susilo, Cheung Man Yung Bernard, Gary Tse @cvanalytics2015 @GaryTse1 @HealthcareAI_UK

Calling for book chapters on the use of big data/new diagnostic technology for cardiovascular diseases Edited by @DrHaipengLiu from Coventry and I. @HealthcareAI_UK @CRCPress forms.office.com/e/TQ9ynYgEq…

Our team found that any OCS use was associated with higher risk of adverse outcomes in patients with COPD, with risk generally increasing with greater cumulative OCS dose. More here at the Int J of COPD: doi.org/10.2147/COPD.S433326 @GaryTse1 @HealthcareAI_UK

Initiating warfarin shortly after IE diagnosis was associated with reduced 90-day mortality risk by 50% compared to non-use. doi.org/10.1016/j.thromres.2… @GaryTse1 @sharen212 @JeffreyChansky @HealthcareAI_UK Published in @ThrombosisRese1

Hot in the press. SGLT2i use is associated with lower risks of syncope vs. DPP4i. Published in EHJ CV Pharmacotherapy. @GaryTse1 @JdongZhou @HealthcareAI_UK academic.oup.com/ehjcvp/adva…

Our team member Dr Helen Huang talks about the use of liver indices to predict AF and stroke in diabetes. Presented at the Liver Meeting in Boston. @AASLDtweets @AASLDFoundation @cvanalytics2015 @HealthcareAI_UK @GaryTse1 @jia

We wrote an editorial back in 2018 on the lack of availability of CVD risk models for non-Western populations. 5 years later we developed our complex AI-driven model. Our team now propose a beside model , incorporating effects of long COVID, Covid vaccines & treatments.@GaryTse1

Congratulations to @gbiondizoccai @GaryTse1 @HarkyAmer @adribaran @LeonardoRoever @Nicholaswschew for making the Stanford Top 2% Scientists (2023) for the Cardiovascular System subfield for single year citations and/or career long citations.

Congratulations to @gbiondizoccai @GaryTse1 @HarkyAmer @adribaran @LeonardoRoever for making the Stanford Top 2% Scientists (2023) for the Cardiovascular System subfield for single year citations and/or career long citations.

Our team developed PowerAI-CVD, the first Chinese-specific, validated AI- powered CVD risk model. @GaryTse1 @HealthcareAI_UK @DrHaipengLiu @AbrahamKWai1 More here: medrxiv.org/cgi/content/shor…

Members of our team presented their oral presentations and moderated posters at the @escardio congress in Amsterdam. @HealthcareAI_UK @GaryTse1